Weiss Lawrence T. - 16 Jul 2026 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 Jul 2026, 20:36:47 UTC
Prior SEC filing
22 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lawrence Weiss

Key filing fact

Weiss Lawrence T. filed Form 4 for ANGIODYNAMICS INC (ANGO) on 21 Jul 2026.

Key facts

  • This page summarizes Weiss Lawrence T.'s Form 4 filing for ANGIODYNAMICS INC (ANGO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Jul 2026, 20:36.

Change

  • Previous filing in this sequence was filed on 22 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001930293 Primary reporting owner

Weiss Lawrence T

Relationship
SVP, Chief Legal Officer
Address
14 PLAZA DRIVE, LATHAM
Signature
/s/ Lawrence Weiss
Signature date
21 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANGO transaction

Common Stock

Tax liability

Transaction value
Shares
-2,267
Change %
-2.4%
Price
$14.14*
Shares after
91,330
Date
16 Jul 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The exempt disposition of 2,267 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .